JCP
STML

Jabre Capital Partners’s Stemline Therapeutics, Inc. STML Stock Holding History

Jabre Capital Partners’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-20,000
Closed -$332K – 117
2018
Q3 		$332K Sell
20,000
-863
-4% -$14.3K 0.11% 97
2018
Q2 		$335K Buy
+20,863
New +$335K 0.02% 128